A new study conducted by researchers from the University of Eastern Finland the Karolinska Institutet explored the ways that ...

Lean mass constituted 30.8% of total body weight lost for adults who received a GLP-1 drug during a randomized controlled ...

Maintaining a healthy weight is good for your body and can also help with self-esteem. If you’ve been trying to lose weight, ...

(liraglutide) weight loss in adults and children ages 12 years ... Avoid compounded drugs marketed as semaglutide, and only take FDA-approved semaglutide products — such as Wegovy, Ozempic ...

LEXX READ THE FULL LEXX RESEARCH REPORT Lexaria Bioscience Corporation (NASDAQ:LEXX) reported fiscal first quarter 2025 ...

Hers shares information about the average weight for women in the U.S., what women believe the ideal weight is, and the ...

Hims & Hers may leverage FDA compounding exemptions to further extend its compounded GLP-1 offerings. Learn why HIMS stock is ...

For its most recently reported quarter (Q3 of 2024), Hims & Hers generated $401.6 million in revenue. That resulted in a free ...

The 30-year-old singer Avery warned people about the dangers of the diabetic medication Ozempic after revealing that she had ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...